KAKEN PHARMACEUTICAL CO.,LTD.

4521 TSE Pharmaceuticals Pharmaceutical
TSE Prime
¥3,830.00
-0.13%
Delayed · cached 15 min
Fair Value Analysis →

Frequently asked questions

What sector does KAKEN PHARMACEUTICAL CO.,LTD. belong to?
KAKEN PHARMACEUTICAL CO.,LTD. operates in the Pharmaceuticals sector, specifically the Pharmaceutical industry, and is listed on the US markets.
What is the current share price of 4521?
As of the latest available quote, 4521 traded at ¥3,830.00. This price is delayed and cached for about 15 minutes.
What is the P/E ratio of 4521?
KAKEN PHARMACEUTICAL CO.,LTD. has a price-to-earnings (P/E) ratio of about 67.57. The P/E ratio compares the share price to earnings per share and is most useful when compared with sector peers and the company's own history.
What is the market capitalisation of 4521?
The market capitalisation of KAKEN PHARMACEUTICAL CO.,LTD. is approximately ¥145.16B.
Is KAKEN PHARMACEUTICAL CO.,LTD. profitable?
For its latest reported financial year, KAKEN PHARMACEUTICAL CO.,LTD. recorded a net profit margin of about 2.79%.
Does 4521 pay a dividend?
KAKEN PHARMACEUTICAL CO.,LTD. currently has a dividend yield of about 4.95%.
What is the return on equity (ROE) of 4521?
KAKEN PHARMACEUTICAL CO.,LTD. has a return on equity (ROE) of about 1.40%. ROE measures how much profit a company generates relative to shareholders' equity.
What is the 52-week high and low of 4521?
Over the past 52 weeks, 4521 has traded between a low of ¥3,540.00 and a high of ¥4,445.00.

These answers are generated from reported financial data and live market figures, for educational and informational purposes only.

Educational data only. Not a recommendation to buy, sell or hold any security.